DIMENSIONAL FUND ADVISORS LP - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$128,245,000
+41.4%
5,518,308
-3.1%
0.05%
+34.2%
Q1 2018$90,686,000
-16.0%
5,696,348
+9.7%
0.04%
-15.6%
Q4 2017$107,933,000
+68.4%
5,194,075
+16.1%
0.04%
+60.7%
Q3 2017$64,086,000
+254.2%
4,472,185
+327.6%
0.03%
+250.0%
Q2 2017$18,092,000
+210.7%
1,045,775
+98.1%
0.01%
+166.7%
Q1 2017$5,823,000
-30.4%
527,920
-8.4%
0.00%
-25.0%
Q4 2016$8,372,000
+10.5%
576,634
+86.9%
0.00%0.0%
Q3 2016$7,575,000
+398.0%
308,518
+308.7%
0.00%
+300.0%
Q2 2016$1,521,000
-27.4%
75,483
-5.1%
0.00%0.0%
Q1 2016$2,094,000
-74.2%
79,577
-0.3%
0.00%
-80.0%
Q4 2015$8,110,000
-41.1%
79,777
+3.2%
0.01%
-44.4%
Q3 2015$13,765,000
-11.9%
77,277
+9.9%
0.01%
-10.0%
Q2 2015$15,619,000
+15.9%
70,312
+3.6%
0.01%
+11.1%
Q1 2015$13,481,000
+49.9%
67,866
+8.0%
0.01%
+50.0%
Q4 2014$8,991,000
+45.2%
62,824
+33.1%
0.01%
+50.0%
Q3 2014$6,192,000
+8.1%
47,197
+4.0%
0.00%0.0%
Q2 2014$5,726,000
+29.7%
45,382
+35.4%
0.00%
+33.3%
Q1 2014$4,415,000
+50.8%
33,521
+34.4%
0.00%
+50.0%
Q4 2013$2,928,000
-6.4%
24,942
-16.8%
0.00%
-33.3%
Q3 2013$3,127,000
+46.7%
29,976
+21.1%
0.00%
+50.0%
Q2 2013$2,131,00024,7560.00%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2016
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders